BONUS BIOGROUP
Bonus BioGroup (TASE: BONS) is a product-focused biotechnology company applying proprietary, innovative technology to supply tissue-regenerating viable bone grafts. It is a pioneer in developing cell therapy and tissue engineering products based on autologous bone implants that enable efficient bone transplantation and provide cell-based bone replacement for repairing bone lesions. Bonus BioGroup developed a novel method to grow unique 3D high-density bone grafts, based on multi-cell 3D cultures. This leads to bone implants which are available on demand, personalized to each patient, safer, cost-effective, and more efficient than any other solution available to date.
BONUS BIOGROUP
Industry:
Biotechnology Health Care
Founded:
2008-01-01
Address:
Haifa, Hefa, Israel
Country:
Israel
Website Url:
http://www.bonus-bio.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving
Stock Details
Official Site Inspections
http://www.bonus-bio.com Semrush global rank: 7.34 M Semrush visits lastest month: 516
- Host name: ampro2.fcomet.com
- IP address: 172.105.70.171
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "Bonus BioGroup"
Bonus BioGroup LTD
This is the power of Bonus Biogroup's innovative cell therapy. Francis Kaldawy (former patient treated with MesenCure™) As a physician, I believe in shaping the future of medicine, and Bonus Biogroup is doing just that. Their product, …See details»
About Us - Bonus BioGroup LTD
Bonus Biogroup's journey to the present day is a testament to its unwavering ambition and commitment to revolutionizing regenerative medicine. The company's patient-centric approach, scientific leadership, and technological …See details»
Leadership - Bonus BioGroup LTD
Ms. Assays is the General Manager of SISMA (www2.sisma.org.il), a non-profit educational organization, and a former member of the National Petroleum Council, Ministry of Energy, …See details»
Bonus BioGroup - Crunchbase Company Profile & Funding
Bonus BioGroup (TASE: BONS) is a product-focused biotechnology company applying proprietary, innovative technology to supply tissue-regenerating viable bone grafts. It is a …See details»
Bonus BioGroup Ltd. (BBIXF) Company Profile & Facts - Yahoo …
See the company profile for Bonus BioGroup Ltd. (BBIXF) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Bonus BioGroup Company Profile | Management and Employees …
Bonus BioGroup Profile and History Since its establishment, Bonus BioGroup has worked to develop cell therapies and tissue-engineered products for bone regeneration. The main …See details»
Bonus BioGroup - Israeli Startup | Startup Nation Finder
Jan 23, 2024 Bonus BioGroup Overview Bonus BioGroup is a product-focused biotechnology company applying proprietary technology to supply tissue-regenerating, viable bone grafts. The company develops cell therapy and …See details»
Bonus BioGroup Company Description - Stock Analysis
Jan 19, 2025 Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products in development include …See details»
Bonus Biogroup - mednux.com
Bonus Biogroup (TASE: BONS) is an advanced clinical-stage biotechnology company developing 'next-generation' therapies for a variety of indications in the regenerative medicine field. As …See details»
Bonus BioGroup - Funding, Financials, Valuation & Investors
Aug 15, 2012 Organization. Bonus BioGroup . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Funding. Bonus BioGroup is …See details»
Bonus BioGroup - Overview, News & Similar companies - ZoomInfo
Jan 17, 2022 Bonus BioGroup Submits Outstanding Phase-II Trial Results for MesenCure, a Treatment for Severe COVID-19, to the Israeli Ministry of Health Tel Aviv, Israel--(Newsfile …See details»
Bonus Biogroup Overview | SignalHire Company Profile
Jul 11, 2021 Bonus Biogroup is a private company that has been in the industry for 43 years. The company currently specializes in the Biotechnology area. The position of the President & …See details»
Bonus BioGroup Ltd Company Profile & Data: stocks, market cap ...
Jan 1, 2025 The company was formerly known as Oceana Advanced Industries Ltd. and changed its name to Bonus BioGroup Ltd. Bonus BioGroup Ltd. was founded in 1981 and is …See details»
Investors - Bonus BioGroup LTD
Embrace the Bonus Biogroup Advantage and join us on our journey to become a global frontrunner in next-generation cell therapy and tissue engineering. Take this opportunity to be …See details»
Bonus BioGroup Ltd. (BBIXF) Company Profile & Overview - Stock …
Dec 10, 2024 Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products in development include …See details»
Bonus BioGroup Reviews | Read Client Reviews of Bonus BioGroup.
Read reviews of Bonus BioGroup. Write and share your personal story. Your experience will help others make the right buying decision. ... Search. Bonus BioGroup Review. Reviews 12. 4.1. …See details»
Bonus BioGroup Ltd. (BONS.TA) - Yahoo Finance Canada
See the company profile for Bonus BioGroup Ltd. (BONS.TA) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Bonus BioGroup Reports 94% Survival Rate for Severe COVID-19 …
Dec 2, 2021 Tel Aviv, Israel--(Newsfile Corp. - December 2, 2021) - Bonus BioGroup or (TASE: BONS) "the Company", a clinical-stage Israeli biotechnology company engaged in the …See details»
Bonus Biogroup Announces U.S. Food and Drug ... - Morningstar
Feb 20, 2025 Bonus Biogroup Ltd. is a biotechnology company conducting advanced clinical studies focused on developing next-generation therapies in regenerative medicine for cell and …See details»
Press Room 2023 - Bonus BioGroup LTD
Bonus Biogroup's Bioinformatics Unit presents its first achievements at the Paris 2023 annual meeting of the International Society for Cell and Gene Therapy (ISCT), highlighting …See details»